185 related articles for article (PubMed ID: 31996211)
1. Case report: recurrent pituitary adenoma has increased load of somatic variants.
Peculis R; Balcere I; Radovica-Spalvina I; Konrade I; Caune O; Megnis K; Rovite V; Stukens J; Nazarovs J; Breiksa A; Kiecis A; Silamikelis I; Pirags V; Klovins J
BMC Endocr Disord; 2020 Jan; 20(1):17. PubMed ID: 31996211
[TBL] [Abstract][Full Text] [Related]
2. Pituitary tumour transforming gene (PTTG) expression correlates with the proliferative activity and recurrence status of pituitary adenomas: a clinical and immunohistochemical study.
Filippella M; Galland F; Kujas M; Young J; Faggiano A; Lombardi G; Colao A; Meduri G; Chanson P
Clin Endocrinol (Oxf); 2006 Oct; 65(4):536-43. PubMed ID: 16984249
[TBL] [Abstract][Full Text] [Related]
3. Corticotroph carcinoma presenting as a silent corticotroph adenoma.
Farrell WE; Coll AP; Clayton RN; Harris PE
Pituitary; 2003; 6(1):41-7. PubMed ID: 14674723
[TBL] [Abstract][Full Text] [Related]
4. A putative role for the aryl hydrocarbon receptor (AHR) gene in a patient with cyclical Cushing's disease.
De Sousa SMC; Manavis J; Feng J; Wang P; Schreiber AW; Scott HS; Torpy DJ
BMC Endocr Disord; 2020 Jan; 20(1):18. PubMed ID: 31996203
[TBL] [Abstract][Full Text] [Related]
5. Prediction of recurrence of nonfunctioning pituitary tumours by loss of heterozygosity analysis.
Buch HN; Raskauskiene D; Bahar A; Bicknell EJ; Farrell WE; Clayton RN
Clin Endocrinol (Oxf); 2004 Jul; 61(1):19-25. PubMed ID: 15212640
[TBL] [Abstract][Full Text] [Related]
6. Non-functioning pituitary adenomas with positive immunoreactivity for ACTH behave more aggressively than ACTH immunonegative tumours but do not recur more frequently.
Bradley KJ; Wass JA; Turner HE
Clin Endocrinol (Oxf); 2003 Jan; 58(1):59-64. PubMed ID: 12519413
[TBL] [Abstract][Full Text] [Related]
7. A PHLDB1 variant associated with the nonfunctional pituitary adenoma.
Kim LH; Kim JH; Namgoong S; Cheong HS; Yoon SJ; Kim EH; Kim SH; Kim SH; Chang JH; Shin HD
J Neurooncol; 2019 Apr; 142(2):223-229. PubMed ID: 30868356
[TBL] [Abstract][Full Text] [Related]
8. Pituispheres Contain Genetic Variants Characteristic to Pituitary Adenoma Tumor Tissue.
Peculis R; Mandrika I; Petrovska R; Dortane R; Megnis K; Nazarovs J; Balcere I; Stukens J; Konrade I; Pirags V; Klovins J; Rovite V
Front Endocrinol (Lausanne); 2020; 11():313. PubMed ID: 32528411
[TBL] [Abstract][Full Text] [Related]
9. Flow cytometric DNA ploidy and cells phase fractions in recurrent human pituitary adenomas. A correlative study of flow cytometric analysis and the expression of proliferating cell nuclear antigen.
Chae YS; Flotte T; Hsu DW; Preffer F; Hedley-Whyte ET
Gen Diagn Pathol; 1996 Oct; 142(2):89-95. PubMed ID: 8950573
[TBL] [Abstract][Full Text] [Related]
10. Next-generation sequencing identifies novel mitochondrial variants in pituitary adenomas.
Németh K; Darvasi O; Likó I; Szücs N; Czirják S; Reiniger L; Szabó B; Kurucz PA; Krokker L; Igaz P; Patócs A; Butz H
J Endocrinol Invest; 2019 Aug; 42(8):931-940. PubMed ID: 30684245
[TBL] [Abstract][Full Text] [Related]
11. Integrated analysis of DNA methylation and mRNA expression profiles to identify key genes involved in the regrowth of clinically non-functioning pituitary adenoma.
Cheng S; Li C; Xie W; Miao Y; Guo J; Wang J; Zhang Y
Aging (Albany NY); 2020 Feb; 12(3):2408-2427. PubMed ID: 32015217
[TBL] [Abstract][Full Text] [Related]
12. Cyclin D1 (CCND1) genotype is associated with tumour grade in sporadic pituitary adenomas.
Simpson DJ; Fryer AA; Grossman AB; Wass JA; Pfeifer M; Kros JM; Clayton RN; Farrell WE
Carcinogenesis; 2001 Nov; 22(11):1801-7. PubMed ID: 11698342
[TBL] [Abstract][Full Text] [Related]
13. Atypical pituitary adenomas: 10 years of experience in a reference centre in Portugal.
Tortosa F; Webb SM
Neurologia; 2016 Mar; 31(2):97-105. PubMed ID: 26300499
[TBL] [Abstract][Full Text] [Related]
14. Whole-exome sequencing studies of nonfunctioning pituitary adenomas.
Newey PJ; Nesbit MA; Rimmer AJ; Head RA; Gorvin CM; Attar M; Gregory L; Wass JA; Buck D; Karavitaki N; Grossman AB; McVean G; Ansorge O; Thakker RV
J Clin Endocrinol Metab; 2013 Apr; 98(4):E796-800. PubMed ID: 23450047
[TBL] [Abstract][Full Text] [Related]
15. Early postoperative growth in non-functioning pituitary adenomas; A tool to tailor safe follow-up.
Øystese KA; Zucknick M; Casar-Borota O; Ringstad G; Bollerslev J
Endocrine; 2017 Jul; 57(1):35-45. PubMed ID: 28516382
[TBL] [Abstract][Full Text] [Related]
16. Whole-Exome Sequencing Study of Thyrotropin-Secreting Pituitary Adenomas.
Sapkota S; Horiguchi K; Tosaka M; Yamada S; Yamada M
J Clin Endocrinol Metab; 2017 Feb; 102(2):566-575. PubMed ID: 27854551
[TBL] [Abstract][Full Text] [Related]
17. Recurrence in pituitary adenomas in childhood and adolescence.
Espay AJ; Azzarelli B; Williams LS; Bodensteiner JB
J Child Neurol; 2001 May; 16(5):364-7. PubMed ID: 11392522
[TBL] [Abstract][Full Text] [Related]
18. Objective criteria for successful transsphenoidal removal of suprasellar nonfunctioning pituitary adenomas. A prospective study.
Honegger J; Ernemann U; Psaras T; Will B
Acta Neurochir (Wien); 2007 Jan; 149(1):21-9; discussion 29. PubMed ID: 17086476
[TBL] [Abstract][Full Text] [Related]
19. The relation of pituitary adenomas invasiveness and the proliferative index measured by immunoexpression of topoisomerase IIα.
Kwinta BM; Wilk A; Trofimiuk-Muldner M; Grzywna E; Krzyżewski RM; Stachura K; Adamek D
Endokrynol Pol; 2018; 69(5):530-535. PubMed ID: 30074233
[TBL] [Abstract][Full Text] [Related]
20. PTTG and Ki-67 expression in pituitary adenomas.
Wierzbicka-Tutka I; Sokołowski G; Bałdys-Waligórska A; Adamek D; Radwańska E; Gołkowski F
Przegl Lek; 2016; 73(2):53-8. PubMed ID: 27197423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
